Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-04

Clinical Trial Update: Mechanism of Allogeneic UCB Therapy in Cerebral Palsy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating allogeneic umbilical cord blood therapy for cerebral palsy in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic Umbilical Cord Blood Therapy

Snippet

Sponsor: Bundang CHA Hospital | Conditions: Cerebral Palsy, Child Development | Phase 1, Phase 2 | Status: COMPLETED